
Feb 16, 2025, 11:14
Myeloma Paper of the Day, February 16th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Observational multicenter Italian study to analyze the profile of myeloma patients who survived 10 years or longer finds age >60, hypoalbuminemia dx, of anti-myeloma therapies equal or >3 as significant prognostic factors.”
“Long-Term Survival with Multiple Myeloma: An Italian Experience”
Authors: Francesca Fazio, Martina Gherardini, Elena Rossi, Maurizio Martelli, Maria Teresa Petrucci et al.
More posts featuring Robert Orlowski.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 30, 2025, 18:52
Mar 30, 2025, 18:31